- Q2 2024 BioXcel Therapeutics Inc Earnings Call TranscriptAug 06, 2024$0.96 (+4.34%)Earnings
- Q4 2023 BioXcel Therapeutics Inc Earnings Call TranscriptMar 12, 2024$2.77 (-4.48%)Earnings
- BioXcel Therapeutics Inc To Host Neuroscience R&D Day TranscriptDec 12, 2023
- Q3 2023 BioXcel Therapeutics Inc Earnings Call TranscriptNov 14, 2023$4.22 (-23.41%)Earnings
- BioXcel Therapeutics Inc To Discuss The Data Results From The Phase 2 Trial of BXCL701 Call TranscriptOct 10, 2023
- Q2 2023 BioXcel Therapeutics Inc Earnings Call TranscriptAug 14, 2023$4.33 (-41.49%)Earnings
- BioXcel Therapeutics Inc To Discuss TRANQUILITY II Top-Line Results Call TranscriptJun 29, 2023
- BioXcel Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- BioXcel Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- BioXcel Therapeutics Inc To Discuss The Pivotal Phase 3 SERENITY III Part 1 Trial Results Call TranscriptMay 25, 2023
- BioXcel Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 BioXcel Therapeutics Inc Earnings Call TranscriptMay 08, 2023$26.33 (+13.64%)Earnings
- Q4 2022 BioXcel Therapeutics Inc Earnings Call TranscriptMar 09, 2023$24.56 (-13.40%)Earnings
- BioXcel Therapeutics Inc To Host BXCL701 Key Opinion Leader Day TranscriptFeb 21, 2023
- BioXcel Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- BioXcel Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 BioXcel Therapeutics Inc Earnings Call TranscriptNov 10, 2022$14.75 (+29.27%)Earnings
- BioXcel Therapeutics Inc Commercial Day TranscriptOct 18, 2022
- Q2 2022 BioXcel Therapeutics Inc Earnings Call TranscriptAug 09, 2022$15.36 (-7.58%)Earnings
- BioXcel Therapeutics Inc at UBS Global Healthcare Conference TranscriptMay 23, 2022
- BioXcel Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 BioXcel Therapeutics Inc Earnings Call TranscriptMay 09, 2022$11.36 (-9.55%)Earnings
- BioXcel Therapeutics Inc To Discuss The FDA Approval Of IGALMI Call TranscriptApr 06, 2022
- BioXcel Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Q4 2021 BioXcel Therapeutics Inc Earnings Call TranscriptMar 10, 2022$18.11 (-4.13%)Earnings
- BioXcel Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Q3 2021 BioXcel Therapeutics Inc Earnings Call TranscriptNov 10, 2021$34.28 (+1.21%)Earnings
- BioXcel Therapeutics Inc To Host Virtual R&D Day TranscriptSep 23, 2021
- Q2 2021 BioXcel Therapeutics Inc Earnings Call TranscriptAug 10, 2021$24.93 (-0.24%)Earnings
- BioXcel Therapeutics Inc Commercial Day TranscriptJun 25, 2021
- BioXcel Therapeutics Inc at Bank of America NAPA Healthcare Conference TranscriptJun 14, 2021
- BioXcel Therapeutics Inc Annual Shareholders Meeting TranscriptJun 11, 2021
- BioXcel Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- BioXcel Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- BioXcel Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 BioXcel Therapeutics Inc Earnings Call TranscriptMay 10, 2021$30.4 (-0.39%)Earnings
- Q4 2020 BioXcel Therapeutics Inc Earnings Call TranscriptMar 11, 2021$47.2 (+4.31%)Earnings
- BioXcel Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- BioXcel Therapeutics, Inc. - Special Call TranscriptJan 05, 2021
- Q3 2020 BioXcel Therapeutics Inc Earnings Call TranscriptNov 12, 2020$55.06 (-2.69%)Earnings
- Q2 2020 BioXcel Therapeutics Inc Earnings Call TranscriptAug 14, 2020$37.52 (-16.08%)Earnings
- BioXcel Therapeutics, Inc. - Special Call TranscriptJul 20, 2020
- BioXcel Therapeutics Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) TranscriptJun 24, 2020
- BioXcel Therapeutics Inc Annual Shareholders Meeting TranscriptMay 20, 2020
- BioXcel Therapeutics Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- BioXcel Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 BioXcel Therapeutics Inc Earnings Call TranscriptMay 12, 2020$40.68 (-5.42%)Earnings
- BioXcel Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Q4 2019 BioXcel Therapeutics Inc Earnings Call TranscriptMar 09, 2020$29.14 (-11.86%)Earnings
- Q3 2019 BioXcel Therapeutics Inc Earnings Call TranscriptNov 14, 2019$4.36 (-4.80%)Earnings
- Q2 2019 BioXcel Therapeutics Inc Earnings Call TranscriptAug 06, 2019$8.85 (-3.17%)Earnings
- BioXcel Therapeutics, Inc. - Special Call TranscriptJul 22, 2019
- BioXcel Therapeutics Inc Corporate Analyst Meeting TranscriptMay 22, 2019
- BioXcel Therapeutics Inc at UBS Global Healthcare Conference TranscriptMay 20, 2019
- BioXcel Therapeutics, Inc. To Discuss Achieved Targeted Exposures of BXCL501 Conference Call TranscriptMay 20, 2019
- Q1 2019 BioXcel Therapeutics Inc Earnings Call TranscriptMay 07, 2019$10.83 (+3.64%)Earnings
- BioXcel Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 BioXcel Therapeutics Inc Earnings Call TranscriptMar 07, 2019$7.91 (-4.93%)Earnings
BioXcel Therapeutics Inc Commercial Day Transcript
Thank you for joining the BioXcel Therapeutics Virtual Commercial Day event highlighting BXCL501 as a potential treatment for the acute treatment of agitation associated with schizophrenia and bipolar disorders. (Operator Instructions) At this time, I would like to turn the call over to Vimal Mehta, Chief Executive Officer of BioXcel Therapeutics.
Thank you, operator. Good afternoon, everyone, and thank you for joining our Commercial Day to discuss our launch strategy for BXCL501, which is currently under FDA review for the acute treatment of agitation associated with schizophrenia and bipolar disorder. As a reminder, during today's presentation, we will be making forward-looking statements regarding our commercialization plans. These statements are subject to risks and uncertainties that may cause actual results to materially differ from those forecasts. A description of these risks can be found in our most recent 10-Q on file with the SEC.
Next slide, please. Joining
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)